88 Oral etoposide (VP-16) every 3 wks. or continuously to elderly patients with small cell lung cancer (SCLC): Preliminary results of a randomized study

Autor:	E. Bork, S. Vallentin, Fred R. Hirsch, S. Ingeberg, Ulrik Lassen, P Dombernowsky, Bengt Bergman, Nina Jeppesen, J. Mejer, Kell Østerlind
Rok vydání:	1997
Předmět:	Pulmonary and Respiratory Medicine Oncology Cancer Research medicine.medical_specialty business.industry law.invention Randomized controlled trial law Internal medicine Medicine Non small cell business Oral etoposide
Zdroj:	Lung Cancer. 18:25
ISSN:	0169-5002
DOI:	10.1016/s0169-5002(97)89367-1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ba007305cf89a80a327cba38c8781857 https://doi.org/10.1016/s0169-5002(97)89367-1 Zobrazit plný text záznamu Full Text from ScienceDirect